Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for FREE ACCESS to this landmark database

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Marcy, S. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Marcy, S. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Treatment Options for Streptococcal Pharyngitis

S. Michael Marcy, MD

UCLA Center for Vaccine Research, Harbor-UCLA Medical Center, 1124 W Carson St, RB3, Torrance, California, smmarcy{at}LABioMed.org.

Group A ß-hemolytic streptococcus, the most common bacterial cause of pharyngitis, is susceptible to treatment with penicillins, macrolides, or cephalosporins. Current treatment guidelines recommend narrow-spectrum penicillins as first-choice therapy. Macrolides (erythromycin) and first-generation oral cephalosporins are recommended as suitable alternative therapy for patients who are allergic to penicillin, the former for patients who do not exhibit immediate-type hypersensitivity to ß-lactam drugs. These guidelines are somewhat outdated and may not adequately consider advantages offered by other agents. Amoxicillin offers better taste, an important consideration when dealing with pediatric patients. Azithromycin and clarithromycin are generally better-tolerated and preferred over erythromycin, and azithromycin offers a simpler and short-course regimen. Group A ß-hemolytic streptococcus resistance to macrolides as a class is a growing problem that should temper their use. Most oral cephalosporins have superior bacteriologic eradication and clinical response compared with narrow-spectrum and broader-spectrum penicillins, and some later-generation cephalosporins are available in simpler once-daily or short-course (5-day) regimens.

Key Words: cephalosporins • macrolides • penicillins • streptococcal pharyngitis.

Clinical Pediatrics, Vol. 46, No. 4 suppl, 36S-45S (2007)
DOI: 10.1177/0009922807299720
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?